Of note, most of the patients with auto-immune polyendocrine syndrome type 1 (APS-1), a disease characterized by the loss of thymic central immune-tolerance, carry anti-IFN auto-Abs [30]; these patients are at risk for severe COVID-19 [4]. Here, IFNA1 is linked to COVID-19.